Roflumilast Patient Selection for Plaque Psoriasis Treatment
Experts describe roflumilast patient selection for plaque psoriasis treatment.
Real World Experience of Roflumilast for Plaque Psoriasis Treatment
Linda Stein Gold, MD, and Jennifer Soung, MD, discuss real world experience of using roflumilast for plaque psoriasis therapy.
Plaque Psoriasis: Tapinarof Long Term Data
Jennifer Soung, MD, review long term data for tapinarof for the treatment of plaque psoriasis.
Plaque Psoriasis Treatment: Tapinarof Tolerability
Experts in plaque psoriasis provide an overview of the itch response and tolerability profile of tapinarof.
Tapinarof: Plaque Psoriasis Phase III Trial Overview
Linda Stein Gold, MD, reviews phase III data for the topical agent tapinarof for the treatment of plaque psoriasis.
Plaque Psoriasis Treatment: Roflumilast Adverse Effects
Linda Stein Gold, MD, and Jennifer Soung, MD, provides an overview of the safety profile and topical vehicle of roflumilast for the treatment of plaque psoriasis.
Roflumilast Itch Response for Plaque Psoriasis Treatment
Linda Stein Gold, MD, discusses the itch response of roflumilast for the treatment for plaque psoriasis.
Plaque Psoriasis Treatment: Roflumilast Phase III Results
Experts in plaque psoriasis discuss the primary endpoint data responses of roflumilast in the DERMIS-1/DERMIS-2 trials.
Roflumilast: Plaque Psoriasis Phase III Trial Overview
Jennifer Soung, MD, provides an overview of the phase III trials, DERMIS-1/DERMIS-2, in which roflumilast was used to treat plaque psoriasis
Evidence Based Treatment Options for Plaque Psoriasis
Linda Stein Gold, MD, and Jennifer Soung, MD, provide an overview of the different, evidence-based topical strategies for treating plaque psoriasis.